PTSD
-
healthTrump's Psychedelic Therapy Push: What You Need to Know
President Trump signs an executive order to fast-track research and FDA approval for psychedelic therapies, sparking debate on mental health treatment and patient safety.
-
healthTrump Greenlights Expedited Access to Psychedelic Drug Treatments
President Trump signs an executive order fast-tracking FDA review for psychedelic drugs like ibogaine, allocating $50 million for federal research into potential PTSD and substance abuse treatments.
-
healthStudy: Misophonia Linked Genetically to Anxiety and Depression
New research indicates a genetic overlap between misophonia, a condition causing extreme distress from certain sounds, and mood disorders like anxiety, depression, and PTSD.
-
healthTrump Accelerates Access to Psychedelic Drug Treatments
President Trump signs executive order to expedite research and treatment access for psychedelic drugs like ibogaine, particularly for veterans.
-
healthVeteran Leads Psilocybin Retreats for PTSD Ahead of FDA Approval
Army veteran Jesse Gould offers psilocybin retreats for PTSD, aiming to provide an alternative to lifelong medication while states explore therapeutic legalization.
-
healthTexas Invests $100 Million in Ibogaine Research for Addiction and PTSD
Texas commits $100 million to ibogaine research, exploring its potential to treat addiction, PTSD, and other medical conditions, signaling a major shift in therapeutic development.
-
healthVeteran Trauma: Unprecedented Ambushes and the Fight for Truth
Former Delta Force commander Pete Blaber discusses the intensity of combat, the critical role of truth and community in healing veteran trauma, and how flawed investigations worsen PTSD.
-
worldIran's Children Bear Scars of Conflict: A Psychological Toll Beyond Ceasefire
The psychological and emotional toll on Iranian children amidst conflict is profound, with trauma and fear persisting long after the fighting stops.